Ranibizumab (Anti-VEGFA)
Product Specifications
CAS Number
347396-82-1
Synonyms
Lucentis
Target
VEGFR
Applications
Protein Tyrosine Kinase
Additionnal Information
Ranibizumab (Anti-VEGFA) is a recombinant humanized IgG1 monoclonal antibody fragment that inhibits (VEGF-A) and degrades angiogenesis throughout the body and in the eye also interrupts the interaction of VEGF with its receptors, and thus prevents the subsequent growth of new blood vessels.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740225-500 1x 500 µL
Major Vault Protein (MVP) (1032), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040158-500 1x 500 µL
Cytokeratin 17 (E3), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC941231-100 1x 100 µL
Eosinophil Peroxidase (AHE-1), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042025-100 1x 100 µL
MMP9 (MMP9/2025R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC402990-500 1x 500 µL
CD63 (Late Endosomes Marker) (LAMP3/2990R), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details